OnCo

Create your OnCo account

One account keeps your watchlist, saved views and cancer choice in sync across your devices, and lets OnCo alert you when a trial or treatment you follow changes. No password: we email you a sign-in link.

Account creation is being switched on. Until then, press Watch on any page and your list stays in this browser.

Living with cancer· Appointment prep

Appointment sheet: PD-L1-high gastric cancer

One page to bring and write on: your details, the questions for PD-L1-high gastric cancer plus your own, the words you may hear, what to bring, the treatments the standard of care names, and room for the answers and agreed next steps. What you type stays in this browser. Print it or save it as a PDF. New to all this? Start with the first 60 days. Orientation, not medical advice.

Tick the questions to print

All of this cancer's questions start ticked. Untick what does not apply; ticks are kept in this browser. .

Your own questions

Shared with the prep pack, so questions you add there appear here too.

Print or save as PDF

Use (or Ctrl+P, Cmd+P on a Mac). To keep a copy, choose Save as PDF as the destination in the print dialog. Only the sheet prints; the controls stay on screen. Your typed notes print where you typed them; empty fields print as ruled lines to write on.

Appointment sheet

PD-L1-high gastric cancer

Prepared with OnCo (onco.cc/prep/gastric-pdl1-high/). Orientation, not medical advice; your team knows your case.

My details

Name
Date of appointment
Hospital and clinician
Who is coming with me

What I know, what is unclear, changes to discuss

Saved in this browser
What I know so far
What is unclear to me
Changes since last time

My questions

20 on the sheet
Newly diagnosed
  1. 1.What is my exact diagnosis, stage, and grade, and which tests established them?
  2. 2.Which biomarkers have been tested on my tumour (for example PD-L1 combined positive score, Epstein-Barr virus in situ hybridisation, Microsatellite instability and mismatch repair, HER2, Claudin 18.2), and what were the results?
  3. 3.Which subtype is my cancer, and does that change the recommended treatment?
  4. 4.Is germline (inherited) genetic testing recommended for me or my family?
Advanced, first line, CPS 5 or above
  1. 5.For my situation (advanced, first line, cps 5 or above), which of the standard options do you recommend and why?
  2. 6.Am I a candidate for Nivolumab, Pembrolizumab, FOLFOX (5-FU, leucovorin, oxaliplatin) or related drugs, and what side effects should I expect?
  3. 7.How do the results of CheckMate 649 and KEYNOTE-859 apply to someone like me?
Advanced, first line, CPS 1 to 4
  1. 8.For my situation (advanced, first line, cps 1 to 4), which of the standard options do you recommend and why?
  2. 9.Am I a candidate for Nivolumab, Pembrolizumab, Zolbetuximab, and what side effects should I expect?
Resectable stage II to III
  1. 10.For my situation (resectable stage ii to iii), which of the standard options do you recommend and why?
  2. 11.Am I a candidate for Durvalumab, FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), and what side effects should I expect?
  3. 12.How do the results of MATTERHORN apply to someone like me?
Second line
  1. 13.For my situation (second line), which of the standard options do you recommend and why?
  2. 14.Am I a candidate for Ramucirumab, Paclitaxel / nab-paclitaxel, and what side effects should I expect?
  3. 15.How do the results of RAINBOW apply to someone like me?
Any stage
  1. 16.Are there clinical trials I could join, for example of MATTERHORN, Tislelizumab, Biomarker-directed first-line quadruplets in gastric cancer, Gotistobart?
  2. 17.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
  3. 18.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
  4. 19.I read that “Two assays with different thresholds leave patients near the cut-off in an uncertain position”. How does that affect my plan?
  5. 20.I read that “Most patients still progress within a year on chemo-immunotherapy”. How does that affect my plan?

The words I may hear

Tests and results to bring

Biomarker results to ask for: PD-L1 combined positive score (28-8 or 22C3 assay), Epstein-Barr virus in situ hybridisation, Microsatellite instability and mismatch repair (overlapping responders), HER2 (must be negative for this pathway), Claudin 18.2 (competing first-line target).

Scans and tests linked to this cancer: Companion diagnostics.

Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.

The treatments I may be offered

From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.

Answers and next steps

Saved in this browser
What I was told
Agreed next steps, dates and who to call